Literature DB >> 21858445

Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids.

Xiaodong Chen1, Sirui Chen2, Chunlin Li2, Yankun Zhu2, Bing Peng3.   

Abstract

T-cell abnormalities are considered important in the pathogenesis of immune thrombocytopenia (ITP). Th1 polarization of the immune response in peripheral blood mononuclear cells (PBMC) has been observed in ITP patients. However, whether the polarization of T-cell subsets exists in splenocytes remains unclear. In the present study, we detected T-cell subsets and macrophage phagocytosis capacity in the spleens of ten ITP patients failing first-line treatment. Compared with traumatic patients, ITP patients had similar percentages of Th1, Tc1, and T1 (Th1 + Tc1) cells, but lower percentages of Th2 and Tc2 cells, which did not, however, reach significant difference. ITP patients had significantly lower percentages of T2 (Th2 + Tc2) cells than the control group (P = 0.035). The ratios of Th1/Th2 and T1/T2 were significantly higher in ITP patients than the control group (P = 0.025 and 0.027, respectively). Splenic macrophages from ITP patients presented significant increase in phagocytic capacity (P < 0.001). The phagocytosis rate in splenic macrophages positively correlated with the ratio of Th1/Th2 (r = 0.767, P = 0.010), but negatively correlated with percentage of Th2 cells (r = -0.804, P = 0.005). The skewed T-cell subsets and enhanced macrophage phagocytosis in the spleen may be closely related to the disease onset and status of ITP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858445     DOI: 10.1007/s12185-011-0908-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  29 in total

1.  Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy.

Authors: 
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

2.  Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry.

Authors:  Ameet Sarpatwari; Drew Provan; Sebhat Erqou; Ravin Sobnack; Foong Way David Tai; Adrian C Newland
Journal:  Br J Haematol       Date:  2010-10-18       Impact factor: 6.998

3.  Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura.

Authors:  M Kuwana; Y Okazaki; Y Ikeda
Journal:  J Thromb Haemost       Date:  2008-09-27       Impact factor: 5.824

4.  Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura.

Authors:  Jingbo Zhang; Daoxin Ma; Xiaojuan Zhu; Xun Qu; Chunyan Ji; Ming Hou
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

5.  A role for T-helper type-1 and type-2 cytokines in the regulation of human monocyte apoptosis.

Authors:  J Estaquier; J C Ameisen
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

6.  Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis.

Authors:  J Pizzuto; R Ambriz
Journal:  Blood       Date:  1984-12       Impact factor: 22.113

7.  Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group.

Authors:  D Ben-Yehuda; S Gillis; A Eldor
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

8.  T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.

Authors:  Bob Olsson; Per-Ola Andersson; Margareta Jernås; Stefan Jacobsson; Björn Carlsson; Lena M S Carlsson; Hans Wadenvik
Journal:  Nat Med       Date:  2003-08-24       Impact factor: 53.440

9.  Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.

Authors:  Feng Zhang; Xiaoxia Chu; Lin Wang; Yuanyuan Zhu; Lizhen Li; Daoxin Ma; Jun Peng; Ming Hou
Journal:  Eur J Haematol       Date:  2006-02-15       Impact factor: 2.997

Review 10.  Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.

Authors:  Diane Nugent; Robert McMillan; Janet L Nichol; Sherrill J Slichter
Journal:  Br J Haematol       Date:  2009-05-14       Impact factor: 6.998

View more
  4 in total

1.  Glucocorticoids inhibit production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.

Authors:  Yun Chen; Min Zhang; Yijie Zheng
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

2.  Toxoplasma gondii infection in the peritoneal macrophages of rats treated with glucocorticoids.

Authors:  Tao Wang; Jiang-Mei Gao; Si-Qi Yi; Guo-Qing Geng; Xiao-Jie Gao; Ji-Long Shen; Fang-Li Lu; Yan-Zi Wen; Geoff Hide; Zhao-Rong Lun
Journal:  Parasitol Res       Date:  2013-11-19       Impact factor: 2.289

3.  Immune thrombocytopenia: serum cytokine levels in children and adults.

Authors:  Srđana Culić; Ilza Salamunić; Paško Konjevoda; Slavica Dajak; Jasminka Pavelić
Journal:  Med Sci Monit       Date:  2013-09-27

4.  Assessment of immune cells and function of the residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients.

Authors:  Hai-Bo Chu; Ting-Guo Zhang; Jian-Hua Zhao; Feng-Guo Jian; Yong-Bo Xu; Tao Wang; Min Wang; Jin-Yuan Tang; Hong-Jie Sun; Kun Li; Wen-Jun Guo; Xiao-Ji Zhu
Journal:  BMC Immunol       Date:  2014-10-08       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.